ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,025Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 2170

$1.28M Total Retail Price of All Prescriptions

Rank: 32 out of 2170

590 Patients Receiving at Least One Drug in Part D
57%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 590 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

15% of this provider’s 590 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

3% of this provider’s 12,916 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
FUROSEMIDE 702 523 1 6
SIMVASTATIN 699 440 2 1
LISINOPRIL 647 418 3 3
OMEPRAZOLE 641 351 4 2
FLUTICASONE PROPIONATE 554 319 5 30
AMLODIPINE BESYLATE 540 397 6 4
GABAPENTIN 460 221 7 14
METFORMIN HCL 424 257 8 8
RANITIDINE HCL 411 275 9 40
METOPROLOL TARTRATE 341 224 10 10
HYDROCODONE-ACETAMINOPHEN 327 153 S3 11 7
ZETIA 320 150 12 78
DONEPEZIL HCL 314 264 13 32
POTASSIUM CHLORIDE 309 204 14 16
ZOLPIDEM TARTRATE 274 91 15 17
HYDROCHLOROTHIAZIDE 260 157 16 9
TRAMADOL HCL 247 132 17 18
MELOXICAM 227 140 18 28
METOPROLOL SUCCINATE 219 108 19 13
ATORVASTATIN CALCIUM 211 139 20 12
NAMENDA 199 188 21 48
CARVEDILOL 196 133 22 26
LEVOTHYROXINE SODIUM 188 127 23 5
IBUPROFEN 184 82 24 105
RISPERIDONE 183 111 25 73
ALENDRONATE SODIUM 179 148 26 36
CARISOPRODOL 172 0 R 27 111
TRAZODONE HCL 171 99 28 38
ROPINIROLE HCL 169 111 29 92
PROAIR HFA 169 101 29 43
QUETIAPINE FUMARATE 162 70 31 88
ADVAIR DISKUS 160 42 32 45
CLONIDINE HCL 157 92 33 54
CYCLOBENZAPRINE HCL 156 108 R 34 52
NAPROXEN 155 78 35 107
OXYCODONE-ACETAMINOPHEN 155 90 S2 35 60
SERTRALINE HCL 152 115 37 25
NEXIUM 149 45 38 22
PRAVASTATIN SODIUM 148 90 39 11
ATENOLOL 147 109 40 23
LACTULOSE 146 90 41 125
CRESTOR 144 81 42 24
LISINOPRIL-HYDROCHLOROTHIAZIDE 140 87 43 20
ALLOPURINOL 139 114 44 29
JANUVIA 130 83 45 80
METOCLOPRAMIDE HCL 129 104 46 127
CLOPIDOGREL 128 89 47 37
AMOXICILLIN 128 68 47 114
MIRTAZAPINE 127 85 49 46
GLIMEPIRIDE 125 70 50 31
ISOSORBIDE MONONITRATE ER 123 67 51 50
WARFARIN SODIUM 123 96 51 15
MEGESTROL ACETATE 121 99 R 53 262
HYDRALAZINE HCL 120 55 54 84
ACTOS 120 73 54 108
ENDOCET 118 31 S2 56 106
CITALOPRAM HBR 117 66 57 19
AMITRIPTYLINE HCL 114 29 R 58 61
NOVOLIN 70-30 110 80 59 217
INSULIN SYRINGE 108 72 60 113
VENTOLIN HFA 105 48 61 102
LANTUS 103 60 62 51
PANTOPRAZOLE SODIUM 103 84 62 39
PLAVIX 101 73 64 58
GLIPIZIDE XL 100 76 65 81
BENZTROPINE MESYLATE 93 29 R 66 172
FLUOXETINE HCL 93 37 66 59
HYDROXYZINE HCL 92 14 R 68 173
NOVOLOG 90 51 69 98
SUCRALFATE 88 59 70 197
POLYETHYLENE GLYCOL 3350 87 56 71 63
LYRICA 87 17 71 90
SINGULAIR 85 53 73 85
DIVALPROEX SODIUM ER 84 0 74 189
PROMETHAZINE HCL 83 21 R 75 70
LIPITOR 83 56 75 83
RAMIPRIL 82 41 77 77
COMBIVENT 82 39 77 112
EXELON 77 75 79 119
NOVOLOG FLEXPEN 77 70 79 171
TRIAMCINOLONE ACETONIDE 76 53 81 128
CELEBREX 75 44 82 89
SPIRIVA 74 56 83 49
PREDNISONE 72 39 84 41
TAMSULOSIN HCL 72 64 84 33
QVAR 71 43 86 269
DICLOFENAC SODIUM 70 46 87 101
BENAZEPRIL HCL 69 44 88 55
GLIPIZIDE 68 28 89 62
HALOPERIDOL 67 34 90 176
LOVASTATIN 65 47 91 34
LOSARTAN POTASSIUM 63 34 92 21
AMLODIPINE BESYLATE-BENAZEPRIL 63 36 92 67
SEROQUEL 62 27 94 168
METHOCARBAMOL 61 0 R 95 205
TIZANIDINE HCL 61 22 95 123
NOVOLIN R 61 43 95 149
CYMBALTA 60 0 98 44
VYTORIN 60 29 98 179
PAROXETINE HCL 59 0 100 65
LEVETIRACETAM 59 11 100 109
KLOR-CON M20 59 36 100 68
MONTELUKAST SODIUM 59 29 100 157
DIOVAN 58 51 104 53
MECLIZINE HCL 57 41 105 134
LANSOPRAZOLE 57 34 105 165
SEROQUEL XR 56 20 107 276
NIFEDIPINE ER 55 27 108 129
DIVALPROEX SODIUM 55 13 108 91
PREMARIN 55 0 R 108 145
LIDODERM 55 25 108 162
CLOTRIMAZOLE-BETAMETHASONE 55 28 108 174
ENALAPRIL MALEATE 54 54 113 64
BUSPIRONE HCL 52 18 114 143
COLCRYS 52 24 114 140
DILTIAZEM 24HR CD 51 33 116 82
FLUCONAZOLE 51 18 116 158
SULFAMETHOXAZOLE-TRIMETHOPRIM 51 32 116 95
AGGRENOX 51 37 116 169
LOSARTAN-HYDROCHLOROTHIAZIDE 50 34 120 42
LEVEMIR FLEXPEN 50 38 120 185
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 8, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.